NR3C1

Clinical trials for NR3C1 explained in plain language.

Never miss a new study

Get alerted when new NR3C1 trials appear

Sign up with your email to follow new studies for NR3C1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Supercharged immune cells take on deadly brain tumors

Disease control Not yet recruiting

This early-stage trial tests a new approach for people with recurrent glioblastoma, an aggressive brain cancer that has come back after standard treatment. Researchers will give patients specially engineered natural killer (NK) cells, either directly into the brain or through an …

Matched conditions: NR3C1

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:32 UTC

NR3C1

Get alerted when new NR3C1 trials appear

Supercharged immune cells take on deadly brain tumors